Skip to main content

Month: September 2021

Qorvo® to Present at the Citi 2021 Global Technology Virtual Conference

GREENSBORO, N.C., Sept. 02, 2021 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Citi 2021 Global Technology Virtual Conference on Monday, September 13, 2021, at 9:40 a.m. Eastern Time. A live webcast of the virtual event will be available on the Company’s web site at the following URL: http://www.qorvo.com (under “Investors”). About QorvoQorvo (Nasdaq: QRVO) makes a better world possible by providing innovative Radio Frequency (RF) solutions at the center of connectivity. We combine product and technology leadership, systems-level expertise and global manufacturing scale to quickly solve our customers’ most complex technical challenges. Qorvo serves diverse high-growth segments of...

Continue reading

Ackroo Announces Results of Annual General Meeting

Ackroo Shareholders Approve all Matters Presented at AGM HAMILTON, Ontario, Sept. 02, 2021 (GLOBE NEWSWIRE) — Ackroo Inc. (TSX-V: AKR, OTC: AKRFF) (“Ackroo” or the “Company”), a loyalty marketing, payments and point-of-sale technology and services provider, announces that all of the nominees proposed as directors and listed in the Company’s management proxy circular for 2021 were elected as directors at the Company’s annual general meeting held virtually on September 1st, 2021. Shareholders also approved the re-appointment of Grant Thornton LLP as the auditor of the Company for the ensuing year, the ratification of the Company’s incentive stock option plan and the approval of Shen Capital to potentially be a control person of the Company. 99 percent of shares voted were cast in favour of each of the nominees, along with all other...

Continue reading

Vor to Participate in Three Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR or the Company), a cell and genome engineering company, today announced that the Company will be participating in three upcoming virtual investor conferences: Morgan Stanley Virtual 19th Annual Global Healthcare ConferenceFireside Chat Date: Friday, September 10, 2021Time: 2:00 PM ET H.C. Wainwright 23rd Annual Global Investment ConferenceDate: Monday, September 13th through Wednesday, September 15th, 2021 Oppenheimer’s Virtual Fall Healthcare Life Sciences & MedTech Summit Presentation Date: Wednesday, September 22, 2021Time: 3:45 PM ET The fireside chat at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference and presentation at the Oppenheimer Virtual Fall Healthcare Life Sciences & MedTech Summit will be webcast live. A pre-recorded...

Continue reading

Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences

LEXINGTON, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that Keros’ President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in two upcoming healthcare conferences. Presentation Details: Event: Morgan Stanley 19th Annual Global Healthcare ConferenceDate/Time: Friday, September 10 at 11:00 AM ETFormat: Fireside Chat Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDate/Time: Available on Monday, September 13 starting at 7:00 AM ETFormat: Corporate Presentation The Morgan Stanley fireside chat presentation will...

Continue reading

Navios Maritime Holdings Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2021

Net Income$24.9 million net income in Q2 2021 $25.1 million net income in H1 2021Revenue47.9% increase to $143.6 million in Q2 2021 38.4% increase to $260.6 million in H1 2021Cash from operating activities$26.0 million cash provided by operating activities in Q2 2021 $1.4 million cash used in operating activities in H1 2021Adjusted EBITDA216.1% increase to $85.9 million in Q2 2021 141.6% increase to $135.1 million in H1 2021Time Charter Equivalent$21,572 per day in Q2 2021 compared to $7,827 per day in Q2 2020 $17,862 per day in H1 2021 compared to $7,451 per day in H1 2020$251.4 million or 22.4% debt reduction YTD$100.0 million redemption of 11.25% Senior Secured Notes Maturity of 11.25% Senior Secured Notes extended to August 2022$153.2 million proceeds from vessel sales YTDGRAND CAYMAN, Cayman...

Continue reading

John Patrick Miller Joins Cowen Research’s Washington Research Group to Cover ESG and Sustainability Policy

NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that John Patrick Miller has joined Cowen Research’s Washington Research Group (“WRG”) to cover ESG and sustainability policy. He will be based in Washington, D.C. and will report to Robert Fagin, Cowen’s Director of Research. “We are excited to expand our renowned Washington Research Group to include coverage of ESG and sustainability, an area of increasing focus for institutional investors and corporations alike. John’s hire speaks to Cowen’s company-wide commitment to ESG and sustainability. His extraordinary experience and perspective will be valuable in our continued commitment to these issues. We are thrilled to have him on board,” said Mr. Fagin. Cowen’s research department consists of 56 senior analysts (including...

Continue reading

Adagene to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

SAN FRANCISCO, Calif. and SUZHOU, China, Sept. 02, 2021 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that Adagene’s Co-founder, Chief Executive Officer and Chairman, Peter Luo, Ph.D., will participate in the Morgan Stanley 19th Annual Global Healthcare Conference to be held virtually September 9-15, 2021. Details on the presentation and Q&A can be found below:Date: Friday, September 10, 2021Time: 2:00 p.m. EasternA live webcast of the presentation will be accessible in the Investors section of the company’s website at https://www.adagene.com. A webcast replay will be available for at least 30 days. About AdageneAdagene Inc. (Nasdaq:...

Continue reading

OneWater Marine Inc. Completes the Acquisition of PartsVu

Expands presence in parts and accessories, further diversifies revenue streams BUFORD, Ga., Sept. 02, 2021 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or “the Company”) announced today that it has completed the previously announced acquisition of PartsVu (“PartsVu”), an online marketplace for OEM marine parts, electronics and accessories. PartsVu enhances the Company’s presence in the marine parts and accessories sector while helping reduce exposure to the cyclicality of boat sales. “We are thrilled to officially welcome the PartsVu team to the OneWater family as we continue to execute on our strategic growth initiatives and drive increased value for our stockholders. The strength of our combined business further solidifies our leadership position in the marine industry and, notably, in the high margin parts...

Continue reading

MasterCraft Boat Holdings, Inc. Reports Record Fourth Quarter and Fiscal 2021 Results

VONORE, Tenn., Sept. 02, 2021 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2021 fourth quarter and year ended June 30, 2021. Fourth Quarter Highlights:Net sales increased to a record $155.5 million, up 204%. Gross margin expanded by 940 basis points to 23.9%. Net income was $16.5 million or $0.87 per diluted share. Diluted Adjusted Net Income per share, a non-GAAP measure, was $0.98. Adjusted EBITDA, a non-GAAP measure, increased to $27.0 million. Adjusted EBITDA margin, a non-GAAP measure, increased to 17.3%.Full Year Highlights:Delivered the most profitable fiscal year in the Company’s history. Net sales increased to a record $525.8 million, up 45%. Gross margin expanded by 390 basis points to 24.7%. Net income was $56.2 million or $2.96 per diluted share. Diluted...

Continue reading

AREV Announces Brian Cameron as Chief Financial Officer

VANCOUVER, British Columbia, Sept. 02, 2021 (GLOBE NEWSWIRE) — AREV LIFE SCIENCES GLOBAL CORP. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce Brian Cameron as Chief Financial Officer (“CFO”), effective September 2, 2021. Mr. Cameron has owned and operated a corporate finance consultancy, Cameron & Associates, since 1983, with offices in Vancouver Canada, Seattle Washington and Phoenix, Arizona. Prior to forming Cameron & Associates, Mr. Cameron was employed by Price Waterhouse Chartered Accountants and subsequently served in various securities regulatory capacities with the British Columbia Securities Commission and the Vancouver Stock Exchange. Cameron & Associates has provided capital formation strategic planning, business plan preparation, integration of private and public capital formation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.